Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Major Histocompatibility Complex | 6 | 2019 | 34 | 2.280 |
Why?
|
| Friend murine leukemia virus | 5 | 2018 | 10 | 1.940 |
Why?
|
| Celiac Disease | 3 | 2022 | 17 | 1.710 |
Why?
|
| Gastrointestinal Microbiome | 8 | 2022 | 122 | 1.690 |
Why?
|
| Intestinal Mucosa | 6 | 2022 | 219 | 1.570 |
Why?
|
| Microbiota | 4 | 2020 | 80 | 1.550 |
Why?
|
| Host-Pathogen Interactions | 5 | 2021 | 69 | 1.480 |
Why?
|
| Retroviridae Infections | 3 | 2015 | 7 | 1.040 |
Why?
|
| Tumor Virus Infections | 3 | 2015 | 32 | 1.030 |
Why?
|
| Genetic Fitness | 3 | 2015 | 8 | 1.020 |
Why?
|
| Intestine, Small | 2 | 2022 | 89 | 0.970 |
Why?
|
| Leukemia, Experimental | 2 | 2015 | 14 | 0.940 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2021 | 77 | 0.900 |
Why?
|
| Homeostasis | 3 | 2022 | 291 | 0.860 |
Why?
|
| Immunoglobulin A | 5 | 2021 | 79 | 0.860 |
Why?
|
| Evolution, Molecular | 2 | 2013 | 79 | 0.820 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 19 | 0.810 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 42 | 0.790 |
Why?
|
| Symbiosis | 4 | 2022 | 19 | 0.780 |
Why?
|
| Heterozygote | 2 | 2019 | 174 | 0.770 |
Why?
|
| Antibodies | 2 | 2019 | 241 | 0.770 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 59 | 0.770 |
Why?
|
| Signal Transduction | 6 | 2022 | 2689 | 0.750 |
Why?
|
| Virulence | 4 | 2015 | 51 | 0.740 |
Why?
|
| Bacteria | 3 | 2022 | 193 | 0.730 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2019 | 7 | 0.700 |
Why?
|
| Intestines | 1 | 2019 | 114 | 0.660 |
Why?
|
| Mice, Inbred BALB C | 5 | 2018 | 532 | 0.660 |
Why?
|
| Genotype | 3 | 2019 | 786 | 0.650 |
Why?
|
| Mice | 13 | 2022 | 8474 | 0.640 |
Why?
|
| Animals | 21 | 2022 | 20881 | 0.620 |
Why?
|
| T-Lymphocytes | 3 | 2019 | 597 | 0.610 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2015 | 15 | 0.600 |
Why?
|
| Salmonella Infections, Animal | 1 | 2015 | 5 | 0.530 |
Why?
|
| Enteritis | 1 | 2015 | 6 | 0.530 |
Why?
|
| Polymorphism, Genetic | 2 | 2015 | 301 | 0.520 |
Why?
|
| Adaptation, Physiological | 2 | 2013 | 189 | 0.500 |
Why?
|
| Host-Parasite Interactions | 1 | 2013 | 6 | 0.450 |
Why?
|
| Disease Resistance | 1 | 2013 | 3 | 0.450 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 14 | 0.440 |
Why?
|
| Metagenome | 1 | 2012 | 17 | 0.420 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 56 | 0.410 |
Why?
|
| Glutens | 2 | 2022 | 10 | 0.380 |
Why?
|
| Antigens, CD19 | 2 | 2022 | 17 | 0.380 |
Why?
|
| Adaptive Immunity | 2 | 2021 | 37 | 0.320 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 2550 | 0.290 |
Why?
|
| Genetic Variation | 3 | 2019 | 220 | 0.280 |
Why?
|
| Biological Evolution | 2 | 2018 | 86 | 0.260 |
Why?
|
| B-Lymphocytes | 2 | 2019 | 329 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 6 | 2022 | 2791 | 0.240 |
Why?
|
| Immunity, Mucosal | 2 | 2021 | 19 | 0.230 |
Why?
|
| Mice, Inbred Strains | 2 | 2015 | 181 | 0.230 |
Why?
|
| Fluorouracil | 2 | 2022 | 130 | 0.210 |
Why?
|
| Colitis | 3 | 2021 | 156 | 0.210 |
Why?
|
| Selection, Genetic | 2 | 2013 | 49 | 0.210 |
Why?
|
| Diet, Gluten-Free | 1 | 2022 | 4 | 0.210 |
Why?
|
| Duodenum | 1 | 2022 | 47 | 0.200 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2021 | 8 | 0.200 |
Why?
|
| Ileum | 1 | 2021 | 28 | 0.200 |
Why?
|
| Dysbiosis | 1 | 2022 | 24 | 0.200 |
Why?
|
| Colonic Neoplasms | 2 | 2022 | 299 | 0.200 |
Why?
|
| Emodin | 1 | 2022 | 21 | 0.200 |
Why?
|
| Female | 9 | 2021 | 38074 | 0.200 |
Why?
|
| Myeloid Cells | 1 | 2021 | 57 | 0.190 |
Why?
|
| Intestinal Absorption | 1 | 2019 | 41 | 0.170 |
Why?
|
| Lymphocyte Count | 1 | 2019 | 53 | 0.170 |
Why?
|
| Metronidazole | 1 | 2019 | 28 | 0.170 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 90 | 0.170 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 561 | 0.170 |
Why?
|
| Epithelial Cells | 1 | 2021 | 431 | 0.160 |
Why?
|
| Homozygote | 1 | 2019 | 119 | 0.160 |
Why?
|
| Mast Cells | 1 | 2019 | 113 | 0.160 |
Why?
|
| Feces | 1 | 2019 | 88 | 0.160 |
Why?
|
| Spleen Focus-Forming Viruses | 1 | 2018 | 1 | 0.150 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 498 | 0.140 |
Why?
|
| Purines | 1 | 2017 | 39 | 0.140 |
Why?
|
| Salmonella enterica | 1 | 2015 | 2 | 0.130 |
Why?
|
| Lactobacillus | 1 | 2015 | 6 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 194 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1070 | 0.130 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2015 | 32 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 179 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2015 | 156 | 0.120 |
Why?
|
| Host Specificity | 1 | 2013 | 1 | 0.110 |
Why?
|
| Serial Passage | 1 | 2013 | 1 | 0.110 |
Why?
|
| Disease Progression | 1 | 2017 | 1038 | 0.110 |
Why?
|
| Mice, Inbred DBA | 1 | 2013 | 120 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2017 | 617 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 1026 | 0.110 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2012 | 7 | 0.110 |
Why?
|
| Phenotype | 1 | 2015 | 947 | 0.100 |
Why?
|
| Animals, Congenic | 1 | 2012 | 2 | 0.100 |
Why?
|
| Virus Integration | 1 | 2012 | 5 | 0.100 |
Why?
|
| Proviruses | 1 | 2012 | 8 | 0.100 |
Why?
|
| Splenomegaly | 1 | 2012 | 13 | 0.100 |
Why?
|
| Histocompatibility Antigens | 1 | 2012 | 12 | 0.100 |
Why?
|
| Models, Immunological | 1 | 2012 | 25 | 0.100 |
Why?
|
| Male | 6 | 2021 | 37321 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 1667 | 0.100 |
Why?
|
| Viral Load | 1 | 2012 | 127 | 0.100 |
Why?
|
| Virus Replication | 1 | 2012 | 104 | 0.100 |
Why?
|
| Inflammation | 2 | 2019 | 1030 | 0.090 |
Why?
|
| Azoxymethane | 2 | 2022 | 28 | 0.090 |
Why?
|
| Dextran Sulfate | 2 | 2022 | 88 | 0.090 |
Why?
|
| Apoptosis | 1 | 2017 | 1641 | 0.090 |
Why?
|
| Models, Biological | 1 | 2013 | 981 | 0.080 |
Why?
|
| Humans | 6 | 2020 | 68618 | 0.060 |
Why?
|
| Dihydrouracil Dehydrogenase (NADP) | 1 | 2022 | 2 | 0.050 |
Why?
|
| Cachexia | 1 | 2022 | 54 | 0.050 |
Why?
|
| Antigens, Bacterial | 1 | 2021 | 54 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2022 | 132 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 213 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 199 | 0.040 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2019 | 17 | 0.040 |
Why?
|
| Macrophages | 1 | 2022 | 647 | 0.040 |
Why?
|
| Colon | 1 | 2019 | 168 | 0.040 |
Why?
|
| Cell Line | 1 | 2021 | 1752 | 0.040 |
Why?
|
| Cytokines | 1 | 2022 | 866 | 0.040 |
Why?
|
| Rhodotorula | 1 | 2017 | 2 | 0.040 |
Why?
|
| Antibodies, Fungal | 1 | 2017 | 9 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1692 | 0.040 |
Why?
|
| fas Receptor | 1 | 2017 | 54 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 56 | 0.040 |
Why?
|
| Uric Acid | 1 | 2017 | 37 | 0.040 |
Why?
|
| Colony Count, Microbial | 1 | 2017 | 77 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 72 | 0.030 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 133 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 173 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 1076 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2016 | 215 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 1515 | 0.030 |
Why?
|
| Pregnancy | 1 | 2012 | 2334 | 0.020 |
Why?
|